Global Metabolomics Market US$ 1.5 Billion by 2021

Global Metabolomics Market US$ 1.5 Billion by 2021

Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which are the end products of cellular processes. mRNA gene expression data and proteomic analyses reveal the set of gene products being produced in the cell, data that represents one aspect of cellular function including systems biology and functional genomics that integrates proteomic, transcriptomic, and metabolomic information to provide a better understanding of cellular biology.

The global metabolomics market is estimated to reach US$ 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market 2017-2021, published by iHealthcareAnalyst, Inc.

Visit the Metabolomics Market 2017-2021 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/

The metabolomics market report estimates the market size (Revenue US$ million – 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug assessment, and nutrigenomics), and forecasts growth trends (CAGR% – 2017 to 2021). It also provides the detailed market landscape and profiles of major competitors in the global metabolomics market including company overview, financial snapshot, key products, technologies and services offered, and recent trends in strategic management.

The global metabolomics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Technique
    • Detection Techniques
    • Separation Techniques
  1. Application
    • Biomarker Discovery
    • Clinical Toxicology
    • Drug Assessment
    • Nutrigenomics
  1. Company Profiles
    • Agilent Technologies Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Human Metabolome Technologies Inc.
    • LECO Corporation
    • Metabolon Inc.
    • Shimadzu Corporation
    • ThermoFisher Scientific Inc.
    • Waters Corporation

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T09:40:25+00:00 Categories: Press Releases|